NTN1 and cardiac hypertrophy: Furthermore, PGE1 has been found to mitigate angiotensin II (AngII)-induced cardiac hypertrophy by activating of the EP3 receptor, which upregulates Netrin-1 and inhibits the downstream MAPK signaling pathway (Shen et al., 2021).